NCX-1728

N/A

Report date: 2023/05/22 10:20:18

Base Information

Drug NameNCX-1728
Drug Alias NameNCX-1728
ClassificationSmall molecules
Mechanisms of ActionNitric oxide donorsPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 5A
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNicox
China Registration ClassN/A

Develop Information

Active CompaniesNicoxGlaukos Corp
Inactive CompaniesN/A
Active IndicationsGlaucoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A